Compare MYGN & HLLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MYGN | HLLY |
|---|---|---|
| Founded | 1991 | 1903 |
| Country | United States | United States |
| Employees | N/A | 1483 |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Auto Parts:O.E.M. |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 444.2M | 395.5M |
| IPO Year | 1996 | N/A |
| Metric | MYGN | HLLY |
|---|---|---|
| Price | $4.16 | $2.89 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 6 |
| Target Price | ★ $7.64 | $4.83 |
| AVG Volume (30 Days) | ★ 983.9K | 508.3K |
| Earning Date | 05-05-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $771,400,000.00 | N/A |
| Revenue This Year | $6.86 | $6.32 |
| Revenue Next Year | $5.45 | $4.98 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 2.33 | N/A |
| 52 Week Low | $3.76 | $1.60 |
| 52 Week High | $8.59 | $4.48 |
| Indicator | MYGN | HLLY |
|---|---|---|
| Relative Strength Index (RSI) | 36.06 | 38.74 |
| Support Level | $3.76 | $2.75 |
| Resistance Level | $5.52 | $3.09 |
| Average True Range (ATR) | 0.29 | 0.16 |
| MACD | -0.04 | -0.02 |
| Stochastic Oscillator | 25.32 | 6.14 |
Myriad Genetics Inc is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. The company develops and commercializes molecular tests that help patients and providers uncover genetic insights. Its tests assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties, supporting earlier detection, more precise treatment, and lowering healthcare costs. Its tests include BRACAnalysis CDx, EndoPredict, FirstGene, Foresight, GeneSight, MyChoice CDx, MyRisk (cancer treatment), MyRisk (cancer risk), Prequel, Precise Tumor, Prolaris, and SneakPeek. The company operates in the US and Rest of World, with maximum revenue from the US.
Holley Inc designs, manufactures, and distributes high-performance automotive aftermarket products to car and truck enthusiasts in the United States, Canada and Europe. It manufactures a diversified line of performance automotive products, including carburetors, fuel pumps, fuel injection systems, nitrous oxide injection systems, superchargers, exhaust headers, mufflers, distributors, ignition components, engine tuners and automotive performance plumbing products. It also manufactures exhaust products as well as shifters, converters, transmission kits, transmissions, tuners and automotive software. The company markets its products under brands such as Holley, Holley EFI, MSD, Simpson, Flowmaster, EDGE, Cataclean, and Accel, among others. It operates in single segment.